Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio [Yahoo! Finance]
Chimerix, Inc. (CMRX)
Last chimerix, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.chimerix.com/investor-relations
Company Research
Source: Yahoo! Finance
The transaction, expected to be completed in the second quarter, is subject to customary closing conditions and clearance from regulatory authorities. Jazz expects to fund this deal using its existing cash balance and investments. JAZZ Sets Eyes on CMRX's Rare Oncology Drug After this acquisition is completed, Jazz will add CMRX's lead pipeline drug, dordaviprone. The FDA is currently reviewing this drug under the accelerated approval pathway as a potential treatment for adult and pediatric patients with recurrent H3 K27M-mutant diffuse glioma. A final decision is expected by Aug. 18, 2025. If the Chimerix drug receives approval, it will be the first FDA-approved therapy for this deadly disease and among the first molecularly targeted therapies for
Read more
Impact Snapshot
Event Time:
CMRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CMRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CMRX alerts
High impacting Chimerix, Inc. news events
Weekly update
A roundup of the hottest topics
CMRX
News
- Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 [Yahoo! Finance]Yahoo! Finance
- Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
CMRX
Earnings
- 3/21/25 - Beat
CMRX
Sec Filings
- 4/21/25 - Form S-8
- 4/21/25 - Form S-8
- 4/21/25 - Form S-8
- CMRX's page on the SEC website